Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Stem Cells in Drug Discovery 2015

Stem Cells in Drug Discovery 2015



Keynote Speakers


Michael Clements
Scientist, GE Healthcare


Wei Zheng
Group Leader, National Institute of Health

Overview

SELECTBIO are pleased to announce, that due to popular demand we will be hosting a workshop on Stem Cells in Drug Discovery from 2nd-3rd June 2015 at Buckingham House, Murray Edwards College in Cambridge, UK. 

Recent findings in developmental and stem cell biology have revolutionised research opportunities available for those seeking effective models for drug discovery. The divulgence of the mechanisms underlying cellular differentiation and reprogramming from signaling, transcriptional, translational and epigenetic events regulating cell fate has illuminated hidden pathways to accurate testing. The ability to grow and differentiate human stem and somatic cell lines is proving to provide a far more effective model for most types of pre-clinical testing. So much so that the FDA is looking into replacing previous models as a matter of urgency. 

At Stem Cells in Drug Discovery 2015, you will benefit from the expert knowledge of leaders into stem cell research who are currently working towards models for drug testing, that were previously thought to be impossible. You will hear from professionals who are currently screening for efficacy and toxicity of experimental compounds using iPS cell lines, and from others who are responsible for developing the techniques and technologies that are enabling them to do so. There will also be discussions involving industry and regulatory developments that are shaping the future of drug discovery.

Agenda Topics

  • Cancer Biology and Stem Cell Signalling
  • Cardiac iPSCs for Drug Discovery
  • Developments from the EBiSC
  • Disease Modelling and Phenotypic Drug Screening
  • Partnering; Academia, Hospitals and Pharma

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Distinguished Faculty

Lauren Drowley, Associate Principal Scientist, AstraZeneca
David Hay, Chair of Tissue Engineering, MRC Centre for Regenerative Medicine, University of Edinburgh
Timothy Allsopp, Co-ordinator IMI EBiSC Project, Pfizer
Zameel Cader, Director and Principal Scientist, IMI StemBANCC, University of Oxford
Davide Danovi, Director, Cell Phenotyping Platform, Kings College London
Joseph Wu, Director/Professor, Stanford University School of Medicine
Francesco Saverio Tedesco, Principal Research Associate, University College London
Faye Drawnel, Scientist, Pharma Research and Early Development, Roche
Chris Ward, Senior Lecturer, University of Manchester
Gary Gintant, Senior Research Fellow, Abbvie
Lorenz Mayr, Vice President, AstraZeneca Ltd


Corporate SponsorsWeb SponsorsOffical Journal PartnerNetworking
Drug Discovery WorldU-Networks